Belimumab in Autoimmune Hepatitis
Belimumab in Autoimmune Hepatitis
Recruiting · NCT06381453 · Registry updated 2026-04-24Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Belimumab in Autoimmune Hepatitis | Digestive System Diseases, Hepatitis, Chronic, autoimmune disease, autoimmune hepatitis, hepatitis, immune system disorder, liver disorder | Recruiting | Phase 2 | 2026-04-24 | NCT06381453 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| GlaxoSmithKline | 294 |
| University Health Network, Toronto | 417 |
5 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| G.I Research Institute | Vancouver | Canada | 1 |
| London Health Sciences Centre | London | Canada | 39 |
| McMaster University | Hamilton | Canada | 16 |
| Toronto General Hospital | Toronto | Canada | 42 |
| University of Calgary | Calgary | Canada | 17 |